Ilva Ferretti
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 13
- Hepatitis C virus research 7
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Liver Disease and Transplantation 2
-
- Metabolism and Genetic Disorders 4
- Co-authors
- Erica VillaAntonella GrottolaFederico ManentiP. ButtafocoM. De PalmaAnna MolesMauro MannoStefano Bellentani
- Journals
- Journal of Hepatology (5 papers)Hepatology (3 papers)British Journal of Cancer (1 paper)Clinical Science (1 paper)Antiviral Therapy (1 paper)
- Partner nations
- ItalyUnited States
In The Last Decade
Ilva Ferretti
22 papers receiving 885 citations
Peers
Comparison fields: 5 of 61
- Hepatology 696
- Epidemiology 618
- Cancer Research 86
- Pathology and Forensic Medicine 87
- Oncology 124
Countries citing papers authored by Ilva Ferretti
This map shows the geographic impact of Ilva Ferretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilva Ferretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilva Ferretti more than expected).
Fields of papers citing papers by Ilva Ferretti
This network shows the impact of papers produced by Ilva Ferretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilva Ferretti. The network helps show where Ilva Ferretti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ilva Ferretti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 7 | |
| 2 | 2004 | 195 | |
| 3 | 2003 | 47 | |
| 4 | 2003 | 0 | |
| 5 | 2002 | 44 | |
| 6 | 2002 | 7 | |
| 7 | 2002 | 1 | |
| 8 | 2001 | 73 | |
| 9 | 2001 | 60 | |
| 10 | 2000 | 187 | |
| 11 | 1998 | 44 | |
| 12 | 1996 | 17 | |
| 13 | Hepatitis C Virus-positive (HCV) Chronic Active Hepatitis (CAH): a randomized controlled trial of IFN ? Colchicine. | 1996 | 2 |
| 14 | 1995 | 14 | |
| 15 | 1995 | 2 | |
| 16 | 1991 | 35 | |
| 17 | 1989 | 36 | |
| 18 | 1985 | 24 | |
| 19 | Sex related differences of sulfobromophthalein hepatic transport in rats | 1984 | 1 |
| 20 | 1982 | 90 |
About Ilva Ferretti
Ilva Ferretti is a scholar working on Hepatology, Clinical Biochemistry, Epidemiology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 23 papers that have together received 918 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Metabolism and Genetic Disorders (4 papers), Estrogen and related hormone effects (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Hepatology (696 citations), Epidemiology (618 citations), Cancer Research (86 citations), Pathology and Forensic Medicine (87 citations) and Oncology (124 citations). Ilva Ferretti has collaborated with scholars based in Italy and United States. Frequent co-authors include Erica Villa, Antonella Grottola, Federico Manenti, P. Buttafoco, M. De Palma, Anna Moles, Mauro Manno, Stefano Bellentani, Mario De Santis and Mariagrazia Del Buono. Their work appears in journals such as Journal of Hepatology, Hepatology, British Journal of Cancer, Clinical Science and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.